49 results
Page 2 of 3
20-F/A
kc72uwen wr
23 Mar 15
Annual report (foreign) (amended)
12:00am
6-K
EX-1.1
t7a87 2op96s3tqag4n
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
424B3
kvgmrjv
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-10.1
gziptg yoi
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
424B3
hy9mpo5gyoku8en8fw
15 Oct 12
Prospectus supplement
12:00am
F-1
n4gzgw
2 Oct 12
Registration statement (foreign)
12:00am
424B3
pu3ovpvzj
28 Mar 12
Prospectus supplement
12:00am
20-F
qw1qd87d
22 Mar 12
Annual report (foreign)
12:00am
6-K
EX-99.2
ca9qpou
16 Feb 12
Current Report, Foreign Issuer
12:00am
20FR12B/A
1b9 vhhfs1942
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
EX-4.1
72mi5lnphsmaqn 6p
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.21
tan3 vexm5mmzu
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.3
kfxacxg4uas17h53pzu
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am